Egalet prices upsized IPO at $12, the midpoint of the $11 to $13 range

By
A A A

Egalet, which is developing abuse-deterrent oral products for the treatment of pain, raised $50 million by offering 4.2 million shares at $12, the midpoint of the range of $11.00 to $13.00. Egalet plans to list on the NASDAQ under the symbol EGLT. Egalet initially filed confidentially on 9/17/2013. Stifel and JMP Securities acted as lead managers on the deal.




The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.



This article appears in: News Headlines , IPOs

Referenced Stocks: EGLT

Renaissance Capital

Renaissance Capital

More from Renaissance Capital:

Related Videos

Stocks

Referenced

100%

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com